International Private Wealth Advisors LLC Purchases Shares of 3,099 Unum Group (NYSE:UNM)

International Private Wealth Advisors LLC purchased a new position in Unum Group (NYSE:UNM) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 3,099 shares of the financial services provider’s stock, valued at approximately $252,000.

Several other institutional investors and hedge funds have also made changes to their positions in UNM. Tounjian Advisory Partners LLC acquired a new stake in Unum Group during the 1st quarter worth about $897,000. Pallas Capital Advisors LLC raised its stake in shares of Unum Group by 14.8% in the first quarter. Pallas Capital Advisors LLC now owns 5,151 shares of the financial services provider’s stock worth $420,000 after purchasing an additional 666 shares during the last quarter. Farther Finance Advisors LLC raised its stake in shares of Unum Group by 33.0% in the first quarter. Farther Finance Advisors LLC now owns 3,455 shares of the financial services provider’s stock worth $283,000 after purchasing an additional 858 shares during the last quarter. First Citizens Bank & Trust Co. lifted its holdings in shares of Unum Group by 14.5% during the first quarter. First Citizens Bank & Trust Co. now owns 6,716 shares of the financial services provider’s stock worth $547,000 after purchasing an additional 848 shares during the period. Finally, Park Avenue Securities LLC lifted its holdings in shares of Unum Group by 2.7% during the first quarter. Park Avenue Securities LLC now owns 12,812 shares of the financial services provider’s stock worth $1,044,000 after purchasing an additional 334 shares during the period. 86.57% of the stock is currently owned by institutional investors and hedge funds.

Unum Group Stock Up 2.0%

Unum Group stock opened at $81.63 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.29 and a quick ratio of 0.28. The stock has a market capitalization of $14.23 billion, a PE ratio of 8.62, a price-to-earnings-growth ratio of 1.14 and a beta of 0.43. The business has a 50 day simple moving average of $78.59 and a 200-day simple moving average of $77.00. Unum Group has a 12 month low of $48.38 and a 12 month high of $84.48.

Unum Group (NYSE:UNM) last released its quarterly earnings results on Tuesday, April 29th. The financial services provider reported $2.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.19 by ($0.15). The company had revenue of $3.09 billion during the quarter, compared to analyst estimates of $3.34 billion. Unum Group had a net margin of 13.81% and a return on equity of 14.91%. Unum Group’s revenue was down 3.4% compared to the same quarter last year. During the same period in the prior year, the business posted $2.12 EPS. On average, analysts anticipate that Unum Group will post 9.14 EPS for the current fiscal year.

Unum Group declared that its board has authorized a share buyback program on Tuesday, February 18th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to purchase up to 7.4% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Unum Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 16th. Investors of record on Friday, April 25th were given a dividend of $0.42 per share. The ex-dividend date was Friday, April 25th. This represents a $1.68 annualized dividend and a dividend yield of 2.06%. Unum Group’s dividend payout ratio (DPR) is presently 19.79%.

Insider Buying and Selling

In other Unum Group news, EVP Elizabeth Claire Ahmed sold 10,000 shares of Unum Group stock in a transaction on Wednesday, May 7th. The shares were sold at an average price of $80.00, for a total transaction of $800,000.00. Following the sale, the executive vice president now owns 51,170 shares of the company’s stock, valued at $4,093,600. The trade was a 16.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.92% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on UNM shares. UBS Group set a $89.00 price target on shares of Unum Group and gave the stock a “neutral” rating in a research report on Friday, May 23rd. Raymond James raised shares of Unum Group from a “market perform” rating to a “strong-buy” rating and set a $108.00 target price for the company in a report on Wednesday, March 5th. Piper Sandler upped their price target on shares of Unum Group from $87.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, April 2nd. Wells Fargo & Company lifted their price objective on Unum Group from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, May 1st. Finally, BMO Capital Markets boosted their price objective on Unum Group from $95.00 to $102.00 and gave the company an “outperform” rating in a report on Monday, March 3rd. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Unum Group has a consensus rating of “Moderate Buy” and a consensus price target of $88.29.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.